IR
Cellid Co.,Ltd. leads research of anti-cancer immunotherapies and Vaccines for preventing infectious diseases
Disclosure
Total of 10posts
| Number | Title | Person with Duty to Submit | Receipt Date |
|---|---|---|---|
| 10 | [Investment Caution] Issue traded by linked accounts with high market influence | 2025-05-08 | |
| 9 | Ex-Rights(유상증자) | KOSDAQ STOCK MKT. | 2025-05-02 |
| 8 | [Revised]Decision on Paid-in Capital Increase | 2025-05-02 | |
| 7 | Initial (Tentative) Issue Price of Rights Offering | 2025-05-02 | |
| 6 | [Revised]Decision on Paid-in Capital Increase | 2025-04-15 | |
| 5 | [Revised]Outcomes of Annual Meeting of Shareholders | 2025-03-26 | |
| 4 | Outcomes of Annual Meeting of Shareholders | 2025-03-26 | |
| 3 | Submission of Audit Report | 2025-03-18 | |
| 2 | Decision on Paid-in Capital Increase | 2025-03-18 | |
| 1 | 30% or More Change in Sales or Profit/Loss(15% or more in the case of large-scale corporations) | 2025-03-07 |
